Skip to content
2000
Volume 25, Issue 3
  • ISSN: 1566-5240
  • E-ISSN: 1875-5666

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a neurobiological and neurodevelopmental disorder with an idiosyncratic genetic base. ADHD presents various characteristics, such as inattention, hyperactivity, and impulsivity. Over the period, ADHD leads to noticeable functional disability. A five- to ten-fold progressed risk of disorder development is observed in the populations with familial history of ADHD. The abnormal structure of the brain in ADHD results in altered neural mechanisms, such as cognition, attention, and memorial function. The mesolimbic, nigrostriatal, and mesocortical pathways in the brain get affected by the deterioration of the levels of dopamine. The hypothesis of dopamine in ADHD and its etiopathology suggests that detained attention and impaired arousal functions are due to reduced levels of do-pamine. The quickest way to improve strategical treatment is by clarifying the etiological aspects of ADHD and identifying the underlying mechanisms of pathophysiology, which will assist in exploring the biomarkers for better diagnosis. The implementation of life course theory is a very important research principle announced by Grand Challenges in Global Health Initiative (GCMHI). Long-term research is needed to define the progression of ADHD. Interdisciplinary collaborations promise a great future for research innovations in ADHD.

Loading

Article metrics loading...

/content/journals/cmm/10.2174/1566524023666230522145950
2025-01-01
2025-07-12
Loading full text...

Full text loading...

References

  1. TaylorE. Antecedents of ADHD: A historical account of diagnostic concepts.Atten. Defic. Hyperact. Disord.201132697510.1007/s12402‑010‑0051‑x21431827
    [Google Scholar]
  2. BarkleyR.A. FischerM. SmallishL. FletcherK. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder.J. Abnorm. Psychol.2002111227928910.1037/0021‑843X.111.2.27912003449
    [Google Scholar]
  3. BiedermanJ. MickE. StephenF.S.V. Age-Dependent decline of symptoms of attention deficit hyperactivity disorder: Impact of remission definition and symptom type.Am J Psychiatry.2000157581681810.1176/appi.ajp.157.5.81610784477
    [Google Scholar]
  4. RamsayJ.R. Cognitive-behavioral therapy for adult ADHD: An integrative psychosocial and medical approach.New York, NYRoutledge2008
    [Google Scholar]
  5. JarrettM.A. OllendickT.H. A conceptual review of the comorbidity of attention-deficit/hyperactivity disorder and anxiety: Implications for future research and practice.Clin. Psychol. Rev.20082871266128010.1016/j.cpr.2008.05.00418571820
    [Google Scholar]
  6. FaraoneS. BiedermanJ. MickE. The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies.Psychol. Med.200636215916510.1017/S003329170500471X16420712
    [Google Scholar]
  7. HalperinJ.M. SchulzK.P. Revisiting the role of the prefrontal cortex in the pathophysiology of attention-deficit/hyperactivity disorder.Psychol. Bull.2006132456058110.1037/0033‑2909.132.4.56016822167
    [Google Scholar]
  8. BarkleyR.A. PetersH. The earliest reference to ADHD in the medical literature? Melchior Adam Weikard’s description in 1775 of “attention deficit” (Mangel der Aufmerksamkeit, Attentio Volubilis).J. Atten. Disord.201216862363010.1177/108705471143230922323122
    [Google Scholar]
  9. RubiaK. AlegriaA.A. CubilloA.I. SmithA.B. BrammerM.J. RaduaJ. Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: A systematic review and meta-analysis.Biol. Psychiatry201476861662810.1016/j.biopsych.2013.10.01624314347
    [Google Scholar]
  10. SpencerT. J. BrownA. SeidmanL. J. ValeraE. M. MakrisN. LomedicoA. FaraoneS. V. BiedermanJ. Effect of psychostimulants on brain structure and function in ADHD: A qualitative literature review of magnetic resonance imaging-based neuroimaging studies.J Clin Psychiatry.201390291710.4088/JCP.12r08287
    [Google Scholar]
  11. BiedermanJ. FaraoneS.V. KeenanK. BenjaminJ. KrifcherB. MooreC. Sprich-BuckminsterS. UgagliaK. JellinekM.S. SteingardR. PerrinJ. KellerM.B. TsuangM.T. BiedermanJ. KeenanK. BenjaminJ. KeenanM. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples.Arch. Gen. Psychiatry199249972873810.1001/archpsyc.1992.018200900560101514878
    [Google Scholar]
  12. BiedermanJ. FaraoneS. KeenanK. KneeD. TsuangM.T. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder.J. Am. Acad. Child Adolesc. Psychiatry199029452653310.1097/00004583‑199007000‑000042387786
    [Google Scholar]
  13. LarssonH. ChangZ. D’OnofrioB.M. LichtensteinP. The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan.Psychol. Med.201444102223222910.1017/S003329171300249324107258
    [Google Scholar]
  14. FrankeB. FaraoneS.V. AshersonP. BuitelaarJ. BauC.H.D. Ramos-QuirogaJ.A. MickE. GrevetE.H. JohanssonS. HaavikJ. LeschK-P. CormandB. ReifA. The genetics of attention deficit/hyperactivity disorder in adults, a review.Mol. Psychiatry2012171096098710.1038/mp.2011.13822105624
    [Google Scholar]
  15. FaraoneS.V. PerlisR.H. DoyleA.E. SmollerJ.W. GoralnickJ.J. HolmgrenM.A. SklarP. Molecular genetics of attention-deficit/hyperactivity disorder.Biol. Psychiatry200557111313132310.1016/j.biopsych.2004.11.02415950004
    [Google Scholar]
  16. AshersonP. GurlingH. Quantitative and molecular genetics of ADHD.Curr. Top. Behav. Neurosci.2011923927210.1007/7854_2011_15521989848
    [Google Scholar]
  17. BurtS.A. Rethinking environmental contributions to child and adolescent psychopathology: A meta-analysis of shared environmental influences.Psychol. Bull.2009135460863710.1037/a001570219586164
    [Google Scholar]
  18. LarssonH. AnckarsaterH. RåstamM. ChangZ. LichtensteinP. Childhood attention-deficit hyperactivity disorder as an extreme of a continuous trait: A quantitative genetic study of 8,500 twin pairs.J. Child Psychol. Psychiatry2012531738010.1111/j.1469‑7610.2011.02467.x21923806
    [Google Scholar]
  19. ChangZ. LichtensteinP. AshersonP.J. LarssonH. Developmental twin study of attention problems: High heritabilities throughout development.JAMA Psychiatry201370331131810.1001/jamapsychiatry.2013.28723303526
    [Google Scholar]
  20. LarssonH. AshersonP. ChangZ. LjungT. FriedrichsB. LarssonJ.O. LichtensteinP. Genetic and environmental influences on adult attention deficit hyperactivity disorder symptoms: A large Swedish population-based study of twins.Psychol. Med.201343119720710.1017/S003329171200106722894944
    [Google Scholar]
  21. MerwoodA. ChenW. RijsdijkF. SkirrowC. LarssonH. ThaparA. KuntsiJ. AshersonP. Genetic associations between the symptoms of attention-deficit/hyperactivity disorder and emotional lability in child and adolescent twins.J. Am. Acad. Child Adolesc. Psychiatry2014532209220.e410.1016/j.jaac.2013.11.00624472255
    [Google Scholar]
  22. SurmanC.B. BiedermanJ. SpencerT. YorksD. CarolynM.B.A. CarterP.B.R. StephenF.M.V. Deficient emotional self-regulation and adult attention deficit hyperactivity disorder: A family risk analysis.Risk Anal.2011168661762310.1176/appi.ajp.2010.1008117221498464
    [Google Scholar]
  23. ChristiansenH. ChenW. OadesR.D. AshersonP. TaylorE.A. Lasky-SuJ. ZhouK. BanaschewskiT. BuschgensC. FrankeB. GabrielsI. ManorI. MarcoR. MüllerU.C. MulliganA. PsychogiouL. RommelseN.N.J. UebelH. BuitelaarJ. EbsteinR.P. EisenbergJ. GillM. MirandaA. MulasF. RoeyersH. RothenbergerA. SergeantJ.A. Sonuga-BarkeE.J.S. SteinhausenH.C. ThompsonM. FaraoneS.V. Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: Familial evidence for a distinct disorder.J. Neural Transm.2008115216317510.1007/s00702‑007‑0837‑y18200434
    [Google Scholar]
  24. KuntsiJ. PintoR. PriceT.S. van der MeereJ.J. Frazier-WoodA.C. AshersonP. The separation of ADHD inattention and hyperactivity-impulsivity symptoms: pathways from genetic effects to cognitive impairments and symptoms.J. Abnorm. Child Psychol.201442112713610.1007/s10802‑013‑9771‑723839718
    [Google Scholar]
  25. ColeJ. BallH.A. MartinN.C. ScourfieldJ. McguffinP. Genetic overlap between measures of hyperactivity/inattention and mood in children and adolescents.J. Am. Acad. Child Adolesc. Psychiatry200948111094110110.1097/CHI.0b013e3181b7666e19797986
    [Google Scholar]
  26. DoyleA.E. FaraoneS.V. Familial links between attention deficit hyperactivity disorder, conduct disorder, and bipolar disorder.Curr Psychiatry Rep20024214652
    [Google Scholar]
  27. RommelseN.N.J. FrankeB. GeurtsH.M. HartmanC.A. BuitelaarJ.K. Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder.Eur. Child Adolesc. Psychiatry201019328129510.1007/s00787‑010‑0092‑x20148275
    [Google Scholar]
  28. LarssonH. SariaslanA. LångströmN. D’OnofrioB. LichtensteinP. Family income in early childhood and subsequent attention deficit/hyperactivity disorder: A quasi-experimental study.J. Child Psychol. Psychiatry201455542843510.1111/jcpp.1214024111650
    [Google Scholar]
  29. BiedermanJ. PettyC.R. FriedR. KaiserR. DolanC.R. SchoenfeldS. DoyleA.E. SeidmanL.J. FaraoneS.V. Educational and occupational underattainment in adults with attention-deficit/hyperactivity disorder: A controlled study.J. Clin. Psychiatry20086981217122210.4088/JCP.v69n080318681752
    [Google Scholar]
  30. LingineniR. K. BiswasS. AhmadN. JacksonB. E. BaeS. SinghK. P. Factors associated with attention deficit/hyperactivity disorder among US children: Results from a national survey.BMC Pediatr2012125010.1186/1471‑2431‑12‑5022583686
    [Google Scholar]
  31. VisserS.N. DanielsonM.L. BitskoR.H. HolbrookJ.R. KoganM.D. GhandourR.M. PerouR. BlumbergS.J. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011.J. Am. Acad. Child Adolesc. Psychiatry20145313446.e210.1016/j.jaac.2013.09.00124342384
    [Google Scholar]
  32. ZwirsB.W.C. BurgerH. SchulpenT.W.J. WiznitzerM. FedderH. BuitelaarJ.K. Prevalence of psychiatric disorders among children of different ethnic origin.J. Abnorm. Child Psychol.200735455656610.1007/s10802‑007‑9112‑917342420
    [Google Scholar]
  33. PolanczykG. Silva deL.M. LessaH.B. BiedermanJ. AugustoR.L. The worldwide prevalence of ADHD: A systematic review and metaregression analysis.Am J Psychiatry2007164694294810.1176/ajp.2007.164.6.94217541055
    [Google Scholar]
  34. MatteB. AnselmiL. SalumG.A. KielingC. GonçalvesH. MenezesA. GrevetE.H. RohdeL.A. ADHD in DSM-5: A field trial in a large, representative sample of 18- to 19-year-old adults.Psychol. Med.201545236137310.1017/S003329171400147025066615
    [Google Scholar]
  35. PolanczykG. JensenP. Epidemiologic considerations in attention deficit hyperactivity disorder: A review and update.Child Adolesc. Psychiatr. Clin. N. Am.2008172245260, vii10.1016/j.chc.2007.11.00618295145
    [Google Scholar]
  36. ScahillL. Schwab-StoneM. Epidemiology of adhd in school-age children.Child Adolesc Psychiatr Clin N Am200099354155, vii
    [Google Scholar]
  37. FarahL.G. FayyadJ.A. EapenV. CassirY. SalamounM.M. TabetC.C. MneimnehZ.N. KaramE.G. ADHD in the Arab world: A review of epidemiologic studies.J. Atten. Disord.200913321122210.1177/108705470832597619372498
    [Google Scholar]
  38. FaraoneS.V. SergeantJ. GillbergC. BiedermanJ. The worldwide prevalence of ADHD: Is it an American condition?World Psychiatry20032210411316946911
    [Google Scholar]
  39. DiamondA. Attention-deficit disorder (attention-deficit/ hyperactivity disorder without hyperactivity): A neurobiologically and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity).Dev. Psychopathol.200517380782510.1017/S095457940505038816262993
    [Google Scholar]
  40. KesslerR.C. JenniferG.G. LenardA.A. Structure and diagnosis of adult attention-deficit/hyperactivity disorder: Analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale.Arch Gen Psychiatry2010671111681178
    [Google Scholar]
  41. McGoughJ.J. SmalleyS.L. McCrackenJ.T. YangM. Melissa DelM. LynnD.E. LooS. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: Findings from multiplex families.Am J Psychiatry.200516291621162710.1176/appi.ajp.162.9.162116135620
    [Google Scholar]
  42. PliszkaS.R. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder.Child Adolesc. Psychiatr. Clin. N. Am.200093525540, vii10.1016/S1056‑4993(18)30105‑610944655
    [Google Scholar]
  43. GrizenkoN. PaciM. JooberR. Is the inattentive subtype of ADHD different from the combined/hyperactive subtype?J. Atten. Disord.201013664965710.1177/108705470934720019767592
    [Google Scholar]
  44. WilensT.E. SpencerT. BiedermanJ. WozniakJ. ConnorD. JellinekM.S. BiedermanJ. Combined pharmacotherapy: An emerging trend in pediatric psychopharmacology.J. Am. Acad. Child Adolesc. Psychiatry199534111011210.1097/00004583‑199501000‑000217860450
    [Google Scholar]
  45. ArnstenA.F.T. RubiaK. Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: Disruptions in neurodevelopmental psychiatric disorders.J. Am. Acad. Child Adolesc. Psychiatry201251435636710.1016/j.jaac.2012.01.00822449642
    [Google Scholar]
  46. ValeraE.M. FaraoneS.V. MurrayK.E. SeidmanL.J. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder.Biol. Psychiatry200761121361136910.1016/j.biopsych.2006.06.01116950217
    [Google Scholar]
  47. XavierC.F. LeeP.P. SharpW. NealJ.M.O. GreensteinD.K. ClasenL.S. BlumenthalJ. D. ReginaJ.M.S. EbensC.L. JamesW.B.M. AlexZ.M. EvansA.C. GieddJ.N. RapoportJ.L. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder.JAMA2002288141740174810.1001/jama.288.14.174012365958
    [Google Scholar]
  48. NakaoT. RaduaJ. RubiaK. Mataix-ColsD. Gray matter volume abnormalities in ADHD: Voxel-based meta-analysis exploring the effects of age and stimulant medication.Am. J. Psychiatry2011168111154116310.1176/appi.ajp.2011.1102028121865529
    [Google Scholar]
  49. DurstonS. PolH.E.H. SchnackH.G. BuitelaarJ.K. SteenhuisM.P. MinderaaR.B. KahnR.S. van engelandH. MagnusR. Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings.J. Am. Acad. Child Adolesc. Psychiatry200443333234010.1097/00004583‑200403000‑0001615076267
    [Google Scholar]
  50. CorteseS. The neurobiology and genetics of Attention-Deficit/Hyperactivity Disorder (ADHD): What every clinician should know.Eur. J. Paediatr. Neurol.201216542243310.1016/j.ejpn.2012.01.00922306277
    [Google Scholar]
  51. ArnstenA.F.T. PliszkaS.R. Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders.Pharmacol. Biochem. Behav.201199221121610.1016/j.pbb.2011.01.02021295057
    [Google Scholar]
  52. KesnerR.P. ChurchwellJ.C. An analysis of rat prefrontal cortex in mediating executive function.Neurobiol. Learn. Mem.201196341743110.1016/j.nlm.2011.07.00221855643
    [Google Scholar]
  53. ShawP. EckstrandK. SharpW. BlumenthalJ. LerchJ.P. GreensteinD. ClasenL. EvansA. GieddJ. RapoportJ.L. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation.Proc. Natl. Acad. Sci.200710449196491965410.1073/pnas.070774110418024590
    [Google Scholar]
  54. ShawP. MalekM. WatsonB. SharpW. EvansA. GreensteinD. Development of cortical surface area and gyrification in attention-deficit/hyperactivity disorder.Biol. Psychiatry201272319119710.1016/j.biopsych.2012.01.03122418014
    [Google Scholar]
  55. de ZeeuwP. SchnackH.G. van BelleJ. WeustenJ. van DijkS. LangenM. BrouwerR.M. van EngelandH. DurstonS. Differential brain development with low and high IQ in attention-deficit/hyperactivity disorder.PLoS One201274e3577010.1371/journal.pone.003577022536435
    [Google Scholar]
  56. McAlonanG.M. CheungV. ChuaS.E. OosterlaanJ. HungS. TangC. LeeC. KwongS. HoT. CheungC. SucklingJ. LeungP.W.L. Age-related grey matter volume correlates of response inhibition and shifting in attention-deficit hyperactivity disorder.Br. J. Psychiatry2009194212312910.1192/bjp.bp.108.05135919182173
    [Google Scholar]
  57. MakrisN. BiedermanJ. ValeraE.M. BushG. KaiserJ. KennedyD.N. CavinessV.S. FaraoneS.V. SeidmanL.J. Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder.Cereb. Cortex20071761364137510.1093/cercor/bhl04716920883
    [Google Scholar]
  58. ShawP. MalekM. WatsonB. GreensteinD. de RossiP. SharpW. Trajectories of cerebral cortical development in childhood and adolescence and adult attention-deficit/hyperactivity disorder.Biol. Psychiatry201374859960610.1016/j.biopsych.2013.04.00723726514
    [Google Scholar]
  59. ShawP. GilliamM. LiverpoolM. WeddleC. MalekM. SharpW. GreensteinD. EvansA. RapoportJ. GieddJ. Cortical development in typically developing children with symptoms of hyperactivity and impulsivity: support for a dimensional view of attention deficit hyperactivity disorder.Am. J. Psychiatry2011168214315110.1176/appi.ajp.2010.1003038521159727
    [Google Scholar]
  60. FooteS.L. Aston-JonesG. BloomF.E. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal.Proc Natl Acad Sci.19807753033303710.1073/pnas.77.5.3033
    [Google Scholar]
  61. Aston-JonesG. RajkowskiJ. CohenJ. Locus coeruleus and regulation of behavioral flexibility and attention.Prog. Brain Res.200012616518210.1016/S0079‑6123(00)26013‑511105646
    [Google Scholar]
  62. MurburgM.M. Catecholamine function in post-traumatic stress disorder: Emerging concepts.Washington, D.C.APA Press19941762
    [Google Scholar]
  63. FinlayJ.M. ZigmondM.J. AbercrombietE.D. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam.Neuroscience199564361962810.1016/0306‑4522(94)00331‑x7715775
    [Google Scholar]
  64. SchultzW. The phasic reward signal of primate dopamine neurons.Adv. Pharmacol.19974268669010.1016/S1054‑3589(08)60841‑89327992
    [Google Scholar]
  65. DeutchA.Y. RothR.H. The determinants of stress-induced activation of the prefrontal cortical dopamine system.Prog. Brain Res.199185C36740310.1016/S0079‑6123(08)62691‑62094906
    [Google Scholar]
  66. MatsumotoM. HikosakaO. Two types of dopamine neuron distinctly convey positive and negative motivational signals.Nature2009459724883784110.1038/nature0802819448610
    [Google Scholar]
  67. Goldman-RakicP.S. Cellular basis of working memory.Neuron.199514347748510.1016/0896‑6273(95)90304‑67695894
    [Google Scholar]
  68. KielingC. GenroJ.P. HutzM.H. RohdeL.A. The −1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD.Am. J. Med. Genet. B. Neuropsychiatr. Genet.2008147B448549010.1002/ajmg.b.3063618081028
    [Google Scholar]
  69. GreeneC.M. BellgroveM.A. GillM. RobertsonI.H. Noradrenergic genotype predicts lapses in sustained attention.Neuropsychologia200947259159410.1016/j.neuropsychologia.2008.10.00318973765
    [Google Scholar]
  70. BedardA-C. IckowiczA. LoganG.D. Hogg-JohnsonS. SchacharR. TannockR. Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication.J Abnorm Child Psychol200331331532710.1023/a:102328561484412774864
    [Google Scholar]
  71. ItamiS. UnoH. Orbitofrontal cortex dysfunction in attention-deficit hyperactivity disorder revealed by reversal and extinction tasks.Neuroreport.200213182453245710.1097/00001756‑200212200‑0001612499848
    [Google Scholar]
  72. McLEANA. DowsonJ. TooneB. YoungS. BazanisE. RobbinsT.W. SahakianB.J. Characteristic neurocognitive profile associated with adult attention-deficit/hyperactivity disorder.Psychol. Med.200434468169210.1017/S003329170300129615099422
    [Google Scholar]
  73. BartusR.T. LevereT.E. Frontal decortication in rhesus monkeys: A test of the interference hypothesis.Brain Res.1977119123324810.1016/0006‑8993(77)90103‑2401465
    [Google Scholar]
  74. BirrellJ.M. BrownV.J. Medial frontal cortex mediates perceptual attentional set shifting in the rat.J. Neurosci.200020114320432410.1523/JNEUROSCI.20‑11‑04320.200010818167
    [Google Scholar]
  75. CastellanosF.X. GieddJ.N. MarshW.L. HamburgerS.D. VaituzisA.C. DicksteinD.P. SarfattiS.E. VaussY.C. SnellJ.W. LangeN. KaysenD. KrainA. L. RitchieG. F. RajapakseJ. C. RapoportJ. L. Attention-Deficit.2013Available from: https://www.cdc.gov/ncbddd/adhd/index.html
    [Google Scholar]
  76. XavierC.F. GieddJ.N. BerquinP.C. Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder.Arch Gen Psychiatry200158328929510.1001/archpsyc.58.3.28911231836
    [Google Scholar]
  77. BerquinP.C. GieddJ.N. JacobsenL.K. HamburgerS.D. KrainA.L. RapoportJ.L. CastellanosF.X. Cerebellum in attention-deficit hyperactivity disorder: A morphometric MRI study.Neurology19985041087109310.1212/WNL.50.4.10879566399
    [Google Scholar]
  78. HillD.E. YeoR.A. CampbellR.A. HartB. VigilJ. BrooksW. Magnetic resonance imaging correlates of attention-deficit/hyperactivity disorder in children.Neuropsychology200317349650610.1037/0894‑4105.17.3.49612959515
    [Google Scholar]
  79. MostofskyS.H. ReissA.L. LockhartP. DencklaM.B. Evaluation of cerebellar size in attention-deficit hyperactivity disorder.J. Child Neurol.199813943443910.1177/0883073898013009049733289
    [Google Scholar]
  80. MackieS. ShawP. LenrootR. PiersonR. GreensteinD.K. NugentT.F.III SharpW.S. GieddJ.N. RapoportJ.L. Cerebellar development and clinical outcome in attention deficit hyperactivity disorder.Am. J. Psychiatry2007164464765510.1176/ajp.2007.164.4.64717403979
    [Google Scholar]
  81. PlessenK.J. BansalR. ZhuH. WhitemanR. AmatJ. QuackenbushG.A. MartinL. DurkinK. BlairC. RoyalJ. HugdahlK. PetersonB.S. Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder.Arch. Gen. Psychiatry200663779580710.1001/archpsyc.63.7.79516818869
    [Google Scholar]
  82. DoughertyD.D. BonabA.A. SpencerT.J. RauchS.L. MadrasB.K. FischmanA.J. Dopamine transporter density in patients with attention deficit hyperactivity disorder.Lancet199935491962132213310.1016/S0140‑6736(99)04030‑1
    [Google Scholar]
  83. OvermeyerS. BullmoreE.T. SucklingJ. SimmonsA. WilliamsS.C.R. SantoshP.J. TaylorE. Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network.Psychol. Med.20013181425143510.1017/S003329170100470611722157
    [Google Scholar]
  84. AylwardE.H. ReissA.L. ReaderM.J. SingerH.S. BrownJ.E. DencklaM.B. Basal ganglia volumes in children with attention-deficit hyperactivity disorder.J. Child Neurol.199611211211510.1177/0883073896011002108881987
    [Google Scholar]
  85. SeidmanL.J. ValeraE.M. MakrisN. MonuteauxM.C. BorielD.L. KelkarK. KennedyD.N. CavinessV.S. BushG. AleardiM. FaraoneS.V. BiedermanJ. Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging.Biol. Psychiatry200660101071108010.1016/j.biopsych.2006.04.03116876137
    [Google Scholar]
  86. HeilmanK.M. PandyaD.N. GeschwindN. Trimodal inattention following parietal lobe ablations.Trans. Am. Neurol. Assoc.1970952592614998763
    [Google Scholar]
  87. CaplanD. Language: structure, processing and disorders.CambridgeMIT Press1992
    [Google Scholar]
  88. SowellE.R. ThompsonP.M. WelcomeS.E. HenkeniusA.L. TogaA.W. PetersonB.S. Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder.Lancet200336293971699170710.1016/S0140‑6736(03)14842‑814643117
    [Google Scholar]
  89. DumR. StrickP. Cingulate motor areas.In Neurobiology of cingulate cortex and limbic thalamus: A comprehensive handbook.BostonBirkhauser1993
    [Google Scholar]
  90. PausT. Primate anterior cingulate cortex: Where motor control, drive and cognition interface.Nat. Rev. Neurosci.20012641742410.1038/3507750011389475
    [Google Scholar]
  91. BushG. LuuP. PosnerM. I. PosnerM. Cognitive and emotional influences in anterior cingulate cortex.Trends Cogn Sci.20004621522210.1016/S1364‑6613(00)01483‑2
    [Google Scholar]
  92. ZametkinAJ NordahlTE GrossM Cerebral glucose metabolism in adults with hyperactivity of childhood onset.N Engl J Med.1990323201361136610.1056/NEJM199011153232001
    [Google Scholar]
  93. RubiaK. OvermeyerS. TaylorE. BrammerM. WilliamsS.C.R. SimmonsA. BullmoreE.T. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: A study with functional MRI.Am J Psychiatry.1999156689189610.1176/ajp.156.6.89110360128
    [Google Scholar]
  94. TammL. MenonV. RingelJ. ReissA.L. Event-related FMRI evidence of frontotemporal involvement in aberrant response inhibition and task switching in attention-deficit/hyperactivity disorder.J. Am. Acad. Child Adolesc. Psychiatry200443111430144010.1097/01.chi.0000140452.51205.8d15502603
    [Google Scholar]
  95. DuncanJ. OwenA.M. Common regions of the human frontal lobe recruited by diverse cognitive demands.Trends Neurosci.2000231047548310.1016/S0166‑2236(00)01633‑711006464
    [Google Scholar]
  96. Goldman-RakicP.S. Topography of cognition: Parallel distributed networks in primate association cortex.Annu. Rev. Neurosci.198811113715610.1146/annurev.ne.11.030188.0010333284439
    [Google Scholar]
  97. Sonuga-BarkeE.J.S. Causal models of attention-deficit/hyperactivity disorder: From common simple deficits to multiple developmental pathways.Biol. Psychiatry200557111231123810.1016/j.biopsych.2004.09.00815949993
    [Google Scholar]
  98. del CampoN. ChamberlainS.R. SahakianB.J. RobbinsT.W. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.Biol. Psychiatry20116912e145e15710.1016/j.biopsych.2011.02.03621550021
    [Google Scholar]
  99. ChoH.S. BaekD.J. BaekS.S. Effect of exercise on hyperactivity, impulsivity and dopamine D2 receptor expression in the substantia nigra and striatum of spontaneous hypertensive rats.J. Exerc. Nutrition Biochem.201418437938410.5717/jenb.2014.18.4.37925671205
    [Google Scholar]
  100. AguiarA. EubigP.A. SchantzS.L. Attention deficit/hyperactivity disorder: A focused overview for children’s environmental health researchers.Environ. Health Perspect.2010118121646165310.1289/ehp.100232620829148
    [Google Scholar]
  101. GoldM.S. BlumK. Oscar-BermanM. BravermanE.R. Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?Postgrad. Med.2014126115317710.3810/pgm.2014.01.273524393762
    [Google Scholar]
  102. VolkowN.D. WangG.J. FowlerJ.S. DingY.S. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.Biol. Psychiatry200557111410141510.1016/j.biopsych.2004.11.00615950015
    [Google Scholar]
  103. VolkowN.D. WangG.J. FowlerJ.S. LoganJ. GerasimovM. MaynardL. DingY.S. GatleyS.J. GiffordA. FranceschiD. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.J Neurosci2001212RC12110.1523/JNEUROSCI.21‑02‑j0001.2001
    [Google Scholar]
  104. SchmidtL.A. FoxN.A. Perez-EdgarK. HuS. HamerD.H. Association of DRD4 with attention problems in normal childhood development.Psychiatr Genet2001111252910.1097/00041444‑200103000‑00005
    [Google Scholar]
  105. LooS.K. SpecterE. SmolenA. HopferC. TealeP.D. ReiteM.L. Functional effects of the DAT1 polymorphism on EEG measures in ADHD.J. Am. Acad. Child Adolesc. Psychiatry200342898699310.1097/01.CHI.0000046890.27264.8812874502
    [Google Scholar]
  106. BarkleyR.A. SmithK.M. FischerM. NaviaB. An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood.Am. J. Med. Genet. B. Neuropsychiatr. Genet.2006141B548749810.1002/ajmg.b.3032616741944
    [Google Scholar]
  107. AartsE. van HolsteinM. HoogmanM. OnninkM. KanC. FrankeB. BuitelaarJ. CoolsR. Reward modulation of cognitive function in adult attention-deficit/hyperactivity disorder.Behav. Pharmacol.2015261 and 2 - Special Issue22724010.1097/FBP.000000000000011625485641
    [Google Scholar]
  108. SergeantJ.A. GeurtsH. HuijbregtsS. ScheresA. OosterlaanJ. The top and the bottom of ADHD: A neuropsychological perspective.Neurosci Biobehav Rev20032758359210.1016/j.neubiorev.2003.08.004
    [Google Scholar]
  109. AmaraS.G. KuharM.J. Neurotransmitter transporters: Recent progress.Annu. Rev. Neurosci.1993161739310.1146/annurev.ne.16.030193.0004458096377
    [Google Scholar]
  110. BrüssM. KunzJ. LingenB. BönischH. Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter.Hum. Genet.199391327828010.1007/BF002182728478011
    [Google Scholar]
  111. MorónJ.A. BrockingtonA. WiseR.A. RochaB.A. HopeB.T. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.J. Neurosci.200222238939510.1523/JNEUROSCI.22‑02‑00389.200211784783
    [Google Scholar]
  112. KimC.H. HahnM.K. JoungY. AndersonS.L. SteeleA.H. Mazei-RobinsonM.S. GizerI. TeicherM.H. CohenB.M. RobertsonD. WaldmanI.D. BlakelyR.D. KimK.S. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder.Proc. Natl. Acad. Sci.200610350191641916910.1073/pnas.051083610317146058
    [Google Scholar]
  113. HohmannS. HohmE. TreutleinJ. BlomeyerD. Jennen-SteinmetzC. SchmidtM.H. EsserG. BanaschewskiT. BrandeisD. LauchtM. Association of norepinephrine transporter (NET, SLC6A2) genotype with ADHD-related phenotypes: Findings of a longitudinal study from birth to adolescence.Psychiatry Res.20152262-342543310.1016/j.psychres.2014.12.02925724484
    [Google Scholar]
  114. JensonD. YangK. Acevedo-RodriguezA. LevineA. BroussardJ.I. TangJ. DaniJ.A. Dopamine and norepinephrine receptors participate in methylphenidate enhancement of in vivo hippocampal synaptic plasticity.Neuropharmacology201590233210.1016/j.neuropharm.2014.10.02925445492
    [Google Scholar]
  115. SomkuwarS.S. KantakK.M. DwoskinL.P. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.J. Neurosci. Methods2015252556310.1016/j.jneumeth.2015.02.00225680322
    [Google Scholar]
  116. SwansonC.J. PerryK.W. Koch-KruegerS. KatnerJ. SvenssonK.A. BymasterF.P. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.Neuropharmacology200650675576010.1016/j.neuropharm.2005.11.02216427661
    [Google Scholar]
  117. CorteseS. KellyC. ChabernaudC. ProalE. Di MartinoA. MilhamM.P. CastellanosF.X. Toward systems neuroscience of ADHD: A meta-analysis of 55 fMRI studies.Am. J. Psychiatry2012169101038105510.1176/appi.ajp.2012.1110152122983386
    [Google Scholar]
  118. PosnerJ. ParkC. WangZ. Connecting the dots: A review of resting connectivity MRI studies in attention-deficit/hyperactivity disorder.Neuropsychol. Rev.201424131510.1007/s11065‑014‑9251‑z24496902
    [Google Scholar]
  119. GrevenC.U. BraltenJ. MennesM. O’DwyerL. van HulzenK.J.E. RommelseN. SchwerenL.J.S. HoekstraP.J. HartmanC.A. HeslenfeldD. OosterlaanJ. FaraoneS.V. FrankeB. ZwiersM.P. Arias-VasquezA. BuitelaarJ.K. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.JAMA Psychiatry201572549049910.1001/jamapsychiatry.2014.316225785435
    [Google Scholar]
  120. van EwijkH. HeslenfeldD.J. ZwiersM.P. BuitelaarJ.K. OosterlaanJ. Diffusion tensor imaging in attention deficit/hyperactivity disorder: A systematic review and meta-analysis.Neurosci. Biobehav. Rev.20123641093110610.1016/j.neubiorev.2012.01.00322305957
    [Google Scholar]
  121. ShawP. De RossiP. WatsonB. WhartonA. GreensteinD. RaznahanA. SharpW. LerchJ.P. ChakravartyM.M. Mapping the development of the basal ganglia in children with attention-deficit/hyperactivity disorder.J. Am. Acad. Child Adolesc. Psychiatry2014537780789.e1110.1016/j.jaac.2014.05.00324954827
    [Google Scholar]
  122. CastellanosF.X. MarguliesD.S. KellyC. UddinL.Q. GhaffariM. KirschA. ShawD. ShehzadZ. Di MartinoA. BiswalB. Sonuga-BarkeE.J.S. RotrosenJ. AdlerL.A. MilhamM.P. Cingulate-precuneus interactions: A new locus of dysfunction in adult attention-deficit/hyperactivity disorder.Biol. Psychiatry200863333233710.1016/j.biopsych.2007.06.02517888409
    [Google Scholar]
  123. KonradK. EickhoffS.B. Is the ADHD brain wired differently? A review on structural and functional connectivity in attention deficit hyperactivity disorder.Hum. Brain Mapp.201031690491610.1002/hbm.2105820496381
    [Google Scholar]
  124. RubiaK. AlegriaA. BrinsonH. Imaging the ADHD brain: Disorder-specificity, medication effects and clinical translation.Expert Rev. Neurother.201414551953810.1586/14737175.2014.90752624738703
    [Google Scholar]
  125. van HulstB.M. de ZeeuwP. DurstonS. Distinct neuropsychological profiles within ADHD: A latent class analysis of cognitive control, reward sensitivity and timing.Psychol. Med.201545473574510.1017/S003329171400179225099923
    [Google Scholar]
  126. JonesD.K. LeemansA. Diffusion tensor imaging.Methods Mol. Biol.201171171112714410.1007/978‑1‑61737‑992‑5_621279600
    [Google Scholar]
  127. FaraoneS.V. GlattS.J. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.J. Clin. Psychiatry201071675476310.4088/JCP.08m04902pur20051220
    [Google Scholar]
  128. FaraoneS.V. BuitelaarJ. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis.Eur. Child Adolesc. Psychiatry201019435336410.1007/s00787‑009‑0054‑319763664
    [Google Scholar]
  129. WolraichM. BrownL. BrownR.T. DuPaulG. EarlsM. FeldmanH.M. GaniatsT.G. KaplanekB. MeyerB. PerrinJ. PierceK. ReiffM. SteinM.T. VisserS. CapersM. DavidsonC. ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.Pediatrics201112851007102210.1542/peds.2011‑265422003063
    [Google Scholar]
  130. FaraoneSV BiedermanJ SpencerTJ AleardiM Comparing the efficacy of medications for ADHD using meta-analysis.MedGenMed2006844
    [Google Scholar]
  131. Turning Attention To ADHD: US Medication Trends for Attention Deficint Hyperactivity Disorder.2014130Available from: https://www.express-scripts.com/corporate/drug-trend-report/turning-attention-adhd
    [Google Scholar]
  132. FredriksenM. HalmøyA. FaraoneS.V. HaavikJ. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: A review of controlled and naturalistic studies.Eur. Neuropsychopharmacol.201323650852710.1016/j.euroneuro.2012.07.01622917983
    [Google Scholar]
  133. ShawM. HodgkinsP. CaciH. YoungS. KahleJ. WoodsA.G. ArnoldL.E. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: Effects of treatment and non-treatment.BMC Med.20121019910.1186/1741‑7015‑10‑9922947230
    [Google Scholar]
  134. LangbergJ.M. BeckerS.P. Does long-term medication use improve the academic outcomes of youth with attention-deficit/hyperactivity disorder?Clin. Child Fam. Psychol. Rev.201215321523310.1007/s10567‑012‑0117‑822678357
    [Google Scholar]
  135. Excellence NIfCAttention deficit hyperactivity disorder: the NICE guideline on diagnosis and management of ADHD in children, young people and adults.LondonThe British Psychological Society and the Royal College of Psychiatrists2009
    [Google Scholar]
  136. PliszkaS. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.J. Am. Acad. Child Adolesc. Psychiatry200746789492110.1097/chi.0b013e318054e72417581453
    [Google Scholar]
  137. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA)Canadian ADHD practice guidelines.3rd edToronto, ONCADDRA2011
    [Google Scholar]
  138. Bolea-AlamañacB. NuttD.J. AdamouM. AshersonP. BazireS. CoghillD. HealD. MüllerU. NashJ. SantoshP. SayalK. Sonuga-BarkeE. YoungS.J. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the british association for psychopharmacology.J. Psychopharmacol.201428317920310.1177/026988111351950924526134
    [Google Scholar]
  139. DanielsonM.L. VisserS.N. Chronis-TuscanoA. DuPaulG.J. A national description of treatment among united states children and adolescents with attention-deficit/hyperactivity disorder.J. Pediatr.2018192240246.e110.1016/j.jpeds.2017.08.04029132817
    [Google Scholar]
  140. RostainA. JensenP.S. ConnorD.F. MiesleL.M. FaraoneS.V. Toward quality care in ADHD: Defining the goals of treatment.J. Atten. Disord.20151929911710.1177/108705471247383523422237
    [Google Scholar]
  141. ArnstenA. LiB. Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions.Biol. Psychiatry200457111377138410.1016/j.bps.2004.08.019
    [Google Scholar]
  142. KrauseK.H. DreselS. KrauseJ. KungH.F. TatschK. LochmüllerH. Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/ hyperactivity disorder: Positive effect of methylphenidate.J. Neurol.200224981116111810.1007/s00415‑002‑0746‑912420715
    [Google Scholar]
  143. SpencerT.J. BiedermanJ. MadrasB.K. DoughertyD.D. BonabA.A. LivniE. MeltzerP.C. MartinJ. RauchS. FischmanA.J. Further evidence of dopamine transporter dysregulation in ADHD: A controlled PET imaging study using altropane.Biol. Psychiatry20076291059106110.1016/j.biopsych.2006.12.00817511972
    [Google Scholar]
  144. Fusar-poliP. PhD. RubiaK. PhD. RossiG. SartoriG. PhD. BalottinU. PhD. Striatal dopamine transporter alterations in ADHD: Pathophysiology or adaptation to psychostimulants? A meta-analysis.Am J Psychiatry2012169326427210.1176/appi.ajp.2011.1106094022294258
    [Google Scholar]
  145. VolkowN.D. WangG.J. TomasiD. KollinsS.H. WigalT.L. NewcornJ.H. TelangF.W. FowlerJ.S. LoganJ. WongC.T. SwansonJ.M. Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.J. Neurosci.201232384184910.1523/JNEUROSCI.4461‑11.201222262882
    [Google Scholar]
  146. WilensT.E. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.J. Clin. Psychopharmacol.2008283S46S5310.1097/JCP.0b013e318173312f18480677
    [Google Scholar]
  147. Learned-CoughlinS.M. BergströmM. SavitchevaI. AscherJ. SchmithV.D. LångstromB. In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography.Biol. Psychiatry200354880080510.1016/S0006‑3223(02)01834‑614550679
    [Google Scholar]
  148. GoodmanR. FordT. RichardsH. GatwardR. MeltzerH. The development and well-being assessment: Description and initial validation of an integrated assessment of child and adolescent psychopathology.J. Child Psychol. Psychiatry200041564565510.1111/j.1469‑7610.2000.tb02345.x10946756
    [Google Scholar]
  149. SchmittK.C. ReithM.E.A. The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors.PLoS One2011610e2579010.1371/journal.pone.002579022043293
    [Google Scholar]
  150. MontoyaA. HervasA. CardoE. ArtigasJ. MardomingoM.J. AldaJ.A. GastaminzaX. García-PolaviejaM.J. GilaberteI. EscobarR. Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder.Curr. Med. Res. Opin.200925112745275410.1185/0300799090331615219785510
    [Google Scholar]
  151. BramsM. MaoA.R. DoyleR.L. Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.Postgrad. Med.20081203698810.3810/pgm.2008.09.190918824827
    [Google Scholar]
  152. BuitelaarJ.K. MichelsonD. DanckaertsM. GillbergC. SpencerT.J. ZuddasA. FariesD.E. ZhangS. BiedermanJ. A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year.Biol. Psychiatry200761569469910.1016/j.biopsych.2006.03.06616893523
    [Google Scholar]
  153. MichelsonD. BuitelaarJ.K. DanckaertsM. GillbergC. SpencerT.J. ZuddasA. FariesD. ZhangS. BiedermanJ. Relapse prevention in pediatric patients with ADHD treated with atomoxetine: A randomized, double-blind, placebo-controlled study.J. Am. Acad. Child Adolesc. Psychiatry200443789690410.1097/01.chi.0000125089.35109.8115213591
    [Google Scholar]
  154. PaulsD.L. PhD. FrankeB. Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder.Am J Psychiatry20111684365377
    [Google Scholar]
  155. LudolphA. UdvardiP. FöhrK. HenesC. LiebauS. DreyhauptJ. Boeckers Atomoxetine affects transcription/translation of the NMDA receptor and the norepinephrine transporter in the rat brain – an in vivo study.Drug Des. Devel. Ther.201371433144610.2147/DDDT.S5044824348020
    [Google Scholar]
  156. SongZ.M. Abou-ZeidO. FangY.Y. α2a adrenoceptors regulate phosphorylation of microtubule-associated protein-2 in cultured cortical neurons.Neuroscience2004123240541810.1016/j.neuroscience.2003.09.01814698748
    [Google Scholar]
  157. SchwerenL.J.S. de ZeeuwP. DurstonS. MR imaging of the effects of methylphenidate on brain structure and function in Attention-Deficit/Hyperactivity Disorder.Eur. Neuropsychopharmacol.201323101151116410.1016/j.euroneuro.2012.10.01423165220
    [Google Scholar]
  158. GhumanJ.K. GhumanH.S. Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers : Is it justified?Paediatr. Drugs20131511810.1007/s40272‑012‑0001‑523329386
    [Google Scholar]
  159. Widenhorn-MüllerK. SchwandaS. ScholzE. SpitzerM. BodeH. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): A randomized placebo-controlled intervention trial.Prostaglandins Leukot. Essent. Fatty Acids2014911-2496010.1016/j.plefa.2014.04.00424958525
    [Google Scholar]
  160. ÖztopD. AltunH. BaskolG. OzsoyS. Oxidative stress in children with attention deficit hyperactivity disorder.Clin. Biochem.20124510-1174574810.1016/j.clinbiochem.2012.03.02722497926
    [Google Scholar]
  161. SpahisS. VanasseM. BélangerS.A. GhadirianP. GrenierE. LevyE. Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder.Prostaglandins Leukot. Essent. Fatty Acids2008791-2475310.1016/j.plefa.2008.07.00518757191
    [Google Scholar]
  162. LoprestiA.L. Oxidative and nitrosative stress in ADHD: possible causes and the potential of antioxidant-targeted therapies.Atten. Defic. Hyperact. Disord.20157423724710.1007/s12402‑015‑0170‑525894292
    [Google Scholar]
  163. CeyhunH.A. GürbüzerN. New hematological parameters as inflammatory biomarkers: systemic immune inflammation index, platerethritis, and platelet distribution width in patients with adult attention deficit hyperactivity disorder.Adv. Neurodev. Disord.20226221122310.1007/s41252‑022‑00258‑635573104
    [Google Scholar]
  164. HillmanC.H. EricksonK.I. KramerA.F. Be smart, exercise your heart: Exercise effects on brain and cognition.Nat. Rev. Neurosci.200891586510.1038/nrn229818094706
    [Google Scholar]
  165. PontifexM.B. SalibaB.J. RaineL.B. PicchiettiD.L. HillmanC.H. Exercise improves behavioral, neurocognitive, and scholastic performance in children with attention-deficit/hyperactivity disorder.J. Pediatr.2013162354355110.1016/j.jpeds.2012.08.03623084704
    [Google Scholar]
  166. HozaB. SmithA.L. ShoulbergE.K. LinneaK.S. DorschT.E. BlazoJ.A. AlerdingC.M. McCabeG.P. A randomized trial examining the effects of aerobic physical activity on attention-deficit/hyperactivity disorder symptoms in young children.J. Abnorm. Child Psychol.201543465566710.1007/s10802‑014‑9929‑y25201345
    [Google Scholar]
  167. LiangX LiR WongSHS SumRKW SitCHP The impact of exercise interventions concerning executive functions of children and adolescents with attention-deficit/hyperactive disorder: A systematic review and meta-analysis.Int J Behav Nutr Phys Act.20211816810.1186/s12966‑021‑01135‑6
    [Google Scholar]
  168. MairbäurlH. Red blood cells in sports: Effects of exercise and training on oxygen supply by red blood cells.Front. Physiol.2013433210.3389/fphys.2013.0033224273518
    [Google Scholar]
  169. CoronaJ.C. Role of oxidative stress and neuroinflammation in attention-deficit/hyperactivity disorder.Antioxidants2020911103910.3390/antiox911103933114154
    [Google Scholar]
  170. Sonuga-BarkeE.J.S. CoghillD. The foundations of next generation attention-deficit/hyperactivity disorder neuropsychology: Building on progress during the last 30 years.J. Child Psychol. Psychiatry20145512e1e510.1111/jcpp.1236025399637
    [Google Scholar]
  171. CoghillD.R. SethS. MatthewsK. A comprehensive assessment of memory, delay aversion, timing, inhibition, decision making and variability in attention deficit hyperactivity disorder: Advancing beyond the three-pathway models.Psychol. Med.20144491989200110.1017/S003329171300254724176104
    [Google Scholar]
  172. PelsserL.M. FrankenaK. ToormanJ. RodriguesP.R. Diet and ADHD, reviewing the evidence: A systematic review of meta-analyses of double-blind placebo-controlled trials evaluating the efficacy of diet interventions on the behavior of children with ADHD.PLoS One2017121e016927710.1371/journal.pone.016927728121994
    [Google Scholar]
  173. CollinsP.Y. PatelV. JoestlS.S. MarchD. InselT.R. DaarA.S. BordinI.A. CostelloE.J. DurkinM. FairburnC. GlassR.I. HallW. HuangY. HymanS.E. JamisonK. KaayaS. KapurS. KleinmanA. OgunniyiA. Otero-OjedaA. PooM-M. RavindranathV. SahakianB.J. SaxenaS. SingerP.A. SteinD.J. AndersonW. DhansayM.A. EwartW. PhillipsA. ShurinS. WalportM. SteinD.J. Grand challenges in global mental health.Nature20114757354273010.1038/475027a21734685
    [Google Scholar]
  174. GelernterJ. Genetics of complex traits in psychiatry.Biol. Psychiatry2015771364210.1016/j.biopsych.2014.08.00525444161
    [Google Scholar]
  175. SagvoldenT. RussellV.A. AaseH. JohansenE.B. FarshbafM. Rodent models of attention-deficit/hyperactivity disorder.Biol. Psychiatry200557111239124710.1016/j.biopsych.2005.02.00215949994
    [Google Scholar]
  176. NortonW.H.J. Toward developmental models of psychiatric disorders in zebrafish.Front. Neural Circuits2013777910.3389/fncir.2013.0007923637652
    [Google Scholar]
  177. van der VoetM. HarichB. FrankeB. SchenckA. ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila.Mol. Psychiatry201621456557310.1038/mp.2015.5525962619
    [Google Scholar]
  178. BrennandK.J. SimoneA. JouJ. Gelboin-BurkhartC. TranN. SangarS. LiY. MuY. ChenG. YuD. McCarthyS. SebatJ. GageF.H. Modelling schizophrenia using human induced pluripotent stem cells.Nature2011473734622122510.1038/nature0991521490598
    [Google Scholar]
  179. ThomeJ. EhlisA.C. FallgatterA.J. KrauelK. LangeK.W. RiedererP. RomanosM. TaurinesR. TuchaO. UzbekovM. GerlachM. Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD.World J. Biol. Psychiatry201213537940010.3109/15622975.2012.69053522834452
    [Google Scholar]
  180. PengX. LinP. ZhangT. WangJ. Extreme learning machine-based classification of ADHD using brain structural MRI data.PLoS One2013811e7947610.1371/journal.pone.007947624260229
    [Google Scholar]
  181. EliaJ. GlessnerJ.T. WangK. TakahashiN. ShtirC.J. HadleyD. SleimanP.M.A. ZhangH. KimC.E. RobisonR. LyonG.J. FloryJ.H. BradfieldJ.P. ImielinskiM. HouC. FrackeltonE.C. ChiavacciR.M. SakuraiT. RabinC. MiddletonF.A. ThomasK.A. GarrisM. MentchF. FreitagC.M. SteinhausenH.C. TodorovA.A. ReifA. RothenbergerA. FrankeB. MickE.O. RoeyersH. BuitelaarJ. LeschK.P. BanaschewskiT. EbsteinR.P. MulasF. OadesR.D. SergeantJ. Sonuga-BarkeE. RennerT.J. RomanosM. RomanosJ. WarnkeA. WalitzaS. MeyerJ. PálmasonH. SeitzC. LooS.K. SmalleyS.L. BiedermanJ. KentL. AshersonP. AnneyR.J.L. GaynorJ.W. ShawP. DevotoM. WhiteP.S. GrantS.F.A. BuxbaumJ.D. RapoportJ.L. WilliamsN.M. NelsonS.F. FaraoneS.V. HakonarsonH. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder.Nat. Genet.2012441788410.1038/ng.101322138692
    [Google Scholar]
  182. ZhuJ. ZhangX. XuY. SpencerT.J. BiedermanJ. BhideP.G. Prenatal nicotine exposure mouse model showing hyperactivity, reduced cingulate cortex volume, reduced dopamine turnover, and responsiveness to oral methylphenidate treatment.J. Neurosci.201232279410941810.1523/JNEUROSCI.1041‑12.201222764249
    [Google Scholar]
  183. OadesR.D. SlusarekM. VeilingS. BondyB. Serotonin platelet-transporter measures in childhood attention-deficit/hyperactivity disorder (ADHD): Clinical versus experimental measures of impulsivity.World J. Biol. Psychiatry2002329610010.3109/1562297020915060712479082
    [Google Scholar]
  184. EddenR.A.E. CrocettiD. ZhuH. GilbertD.L. MostofskyS.H. Reduced GABA concentration in attention-deficit/hyperactivity disorder.Arch. Gen. Psychiatry201269775075310.1001/archgenpsychiatry.2011.228022752239
    [Google Scholar]
  185. FaraoneS.V. Zhang-JamesY. Can sodium/hydrogen exchange inhibitors be repositioned for treating attention deficit hyperactivity disorder? An in silico approach.Am. J. Med. Genet. B. Neuropsychiatr. Genet.2013162771171710.1002/ajmg.b.3215524132903
    [Google Scholar]
  186. AdlerL.D. NierenbergA.A. Review of medication adherence in children and adults with ADHD.Postgrad. Med.2010122118419110.3810/pgm.2010.01.211220107302
    [Google Scholar]
/content/journals/cmm/10.2174/1566524023666230522145950
Loading
/content/journals/cmm/10.2174/1566524023666230522145950
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keyword(s): behavior; Brain; cognition; dopaminergic pathway; hyperkinetic diseases; neurodevelopment
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test